HDAC6 and amyotrophic lateral sclerosis: HDAC6 inhibitory effect in ameliorating ALS-FTD pathology has been tested in C9ORF72 mutation, where its inhibition reduced the accumulation of PolyGA in vivo (del Rosso et al., 2022).